A case of rapidly progressing and poorly differentiated Ip‐type early‐stage colorectal adenocarcinoma

Autor: Atsuko Tsubomoto, Hiroshi Sashiyama, Junichi Koike, Yohei Morita, Osamu Tsutsumi, Yukihiro Hamahata

Publikováno v: DEN Open, Vol 3, Iss 1, Pp n/a-n/a (2023)

Abstract A 36‐year‐old woman visited our hospital with a chief complaint of bleeding during defecation. Colonoscopy revealed a 20‐mm pedunculated polyp in the sigmoid colon, which was en bloc resected under endoscopy. The histopathological diag

Externí odkaz: https://doaj.org/article/41549db28ea24c1392cf86fabbdee5ff

Lymphoepithelioma-Like Carcinoma of the Colon

Autor: Yasuharu Mori, Kazunari Akagi, Masaaki Yano, Hiroshi Sashiyama, Osamu Tsutsumi, Yukihiro Hamahata, Yasunobu Tsujinaka, Akihiko Tsuchida, Jun Matsubayashi

Publikováno v: Case Reports in Gastroenterology, Vol 7, Iss 1, Pp 127-133 (2013)

A 70-year-old female underwent follow-up colonoscopy after colonic polypectomy. The colonoscopy revealed the presence of a 7-mm submucosal tumor in the sigmoid colon. The tumor surface was smooth and covered with normal mucosa. It was diagnosed as a

Externí odkaz: https://doaj.org/article/bdf461a5658e45479a780364b45049d5

A case of colorectal anisakiasis presenting as submucosal tumor diagnosed by endoscopic resection

Autor: Atsuko Tsubomoto, Hiroshi Sashiyama, Osamu Tsutsumi, Yukihiro Hamahata

Publikováno v: Progress of Digestive Endoscopy. 101:67-69

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4e3174159daf0686fdb06c3287379ab7
https://doi.org/10.11641/pde.101.1_67

A case of rapidly progressing and poorly differentiated Ip‐type early‐stage colorectal adenocarcinoma

Autor: Atsuko Tsubomoto, Hiroshi Sashiyama, Junichi Koike, Yohei Morita, Osamu Tsutsumi, Yukihiro Hamahata

Publikováno v: DEN Open. 3

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e65aa1cc21f233ffe0e424d707bdd185
https://doi.org/10.1002/deo2.181

AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study

Autor: Katsuyoshi Matsuoka, Mamoru Watanabe, Toshihide Ohmori, Koichi Nakajima, Tetsuya Ishida, Yoh Ishiguro, Kazunari Kanke, Kiyonori Kobayashi, Fumihito Hirai, Kenji Watanabe, Hidehiro Mizusawa, Shuji Kishida, Yoshiharu Miura, Akira Ohta, Toshifumi Kajioka, Toshifumi Hibi, Satoshi Motoya, Atsuo Maemoto, Mikihiro Fujiya, Toshifumi Ashida, Mitsuru Goto, Takayuki Matsumoto, Yasuo Suzuki, Yukihiro Hamahata, Tomoo Nakagawa, Naoya Kato, Jun Kato, Yutaka Endo, Ryoichi Suzuki, Koichiro Matsuda, Naoki Ohmiya, Shinji Katsushima, Shuhei Hosomi, Ken-ichi Tarumi, Chiyuki Watanabe, Mitsuru Saito, Yuichiro Yokoyama, Tomoki Inaba, Yasuhisa Sakata, Hitoshi Hongo, Tomoyoshi Shibuya, Kazuhiko Kawakami, Yoichi Kakuta, Atsushi Irisawa, Naoki Yoshimura, Katsuyuki Fukuda, Takayuki Shirai, Hitoshi Ichikawa, Junko Nagata, Takayoshi Suzuki, Kaoru Yokoyama, Takashi Tomidokoro, Yuichiro Kojima, Masahiro Yamada, Hideko Yamamoto, Takayuki Yamamoto, Noriyuki Horiki, Hirozumi Obata, Satoko Inoue, Shinji Tanaka, Tatsuya Toyokawa, Masaki Kunihiro, Takashi Hisabe, Shinichi Ogata, Fuminao Takeshima, Kayoko Matsushima, Nobuyuki Matsuhashi, Hirotake Sakuraba, Masahiro Iwabuchi, Akihiko Tsuchiya, Kan Uchiyama, Takanori Kanai, Masanao Nakamura, Tadashi Yokoyama, Nobuyuki Hida, Keiichi Mitsuyama, Taro Osada, Sakiko Hiraoka, Tomoyuki Tsuzuki, Takashige Masuo, Ryota Hokari, Taku Kobayashi, Masayuki Saruta, Masao Araki, Hiroshi Araki, Masahito Shimizu, Masakazu Kikuchi, Takahiro Nishikawa, Hidetoshi Takedatsu, Kunihiko Aoyagi, Toshiaki Ochiai, Nobuo Toda, Yuji Mizokami, Masakazu Nagahori, Kazuhiro Matsueda, Hitoshi Kino, Akira Kanamori, Tsunehiro Suzuki, Toshiharu Sakurai, Masatoshi Kudo, Atsuo Kitano, Tadakazu Hisamatsu, Shinji Kumagai, Tomoyuki Ninomiya, Kenichiro Mori, Shun-ichi Yoshida, Mitsuhide Goto

Publikováno v: The lancet. Gastroenterologyhepatology. 7(7)

AJM300 is an oral, small-molecule α4-integrin antagonist. We assessed the efficacy and safety of AJM300 in patients with moderately active ulcerative colitis.This multicentre, randomised, double-blind, placebo-controlled, phase 3 study consisted of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09095d091fd13d05f8f0e8950f2cdefb
https://pubmed.ncbi.nlm.nih.gov/35366419